Bank Of Hawaii Novo Nordisk A S Transaction History

Bank Of Hawaii

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $248,140 - $325,001	-5,017 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$49.86 - $58.26 $250,147 - $292,290	5,017 New	5,017 $290,000
Q3 2019 Nov 15, 2019	SELL	$47.54 - $53.43 $247,873 - $278,584	-5,214 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$46.79 - $52.47 $702,879 - $788,204	-15,022 Reduced 74.23%	5,214 $266,000
Q1 2019 May 10, 2019	SELL	$46.36 - $52.63 $796,650 - $904,393	-17,184 Reduced 45.92%	20,236 $1.06 Million
Q4 2018 Feb 13, 2019	SELL	$41.54 - $47.25 $79,009 - $89,869	-1,902 Reduced 4.84%	37,420 $1.72 Million
Q3 2018 Nov 09, 2018	BUY	$46.76 - $51.24 $16,038 - $17,575	343 Added 0.88%	39,322 $1.85 Million
Q2 2018 Aug 06, 2018	SELL	$44.29 - $50.42 $32,730 - $37,260	-739 Reduced 1.86%	38,979 $1.8 Million
Q1 2018 May 04, 2018	BUY	$48.49 - $58.14 $188,044 - $225,466	3,878 Added 10.82%	39,718 $1.96 Million
Q4 2017 Feb 12, 2018	BUY	$47.53 - $53.73 $8,935 - $10,101	188 Added 0.53%	35,840 $1.92 Million
Q3 2017 Nov 03, 2017	BUY	$41.15 - $49.22 $390,554 - $467,147	9,491 Added 36.28%	35,652 $1.72 Million
Q2 2017 Aug 14, 2017	BUY	N/A	26,161	26,161 $1.12 Million

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

Stay updated on Bank Of Hawaii with notifications on news.